CALT - Calliditas Therapeutics AB - ADR
Previous close
40.52
0 0%
Share volume: 4,417
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$40.52
0.00
0.00%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-2.65%
Return on assets
-2.59%
Return on sales
0%
Return on invested capital
498.24%
Total debt ratio
5.93%
Debt ratio change over timeo
-0.97%
Current Ratio
19.23%
Quick Ratio
0%
Cash Position Ratio
17.97%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.45%
Return on assets
-1.54%
Return on sales
0%
Return on invested capital
585.53%
Total debt ratio
6.19%
Debt ratio change over timeo
-0.97%
Current Ratio
18.93%
Quick Ratio
0%
Cash Position Ratio
17.42%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-9%
Return on assets
-9.35%
Return on sales
0%
Return on invested capital
193.93%
Total debt ratio
7.62%
Debt ratio change over time
-0.9%
Current Ratio
13.31%
Quick Ratio
0%
Cash Position Ratio
12.75%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-100.26%
Return on assets
-100.34%
Return on sales
0%
Return on invested capital
-309.07%
Total debt ratio
-96.68%
Debt ratio change over time
-0.97%
Current Ratio
3.21%
Quick Ratio
0%
Cash Position Ratio
2.41%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CALT | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -2.65% | 16.32% | 20.07% | 4.62% |
| Return on assets | -2.59% | 3.37% | 11.64% | 3.4% |
| Return on sales | 0% | 23.81% | 42.11% | 26.22% |
| Return on invested capital | 498.24% | 4.94% | -276.8% | 4.34% |
| Profitability | 25% | 42% | 75% | 29% |
| Total debt ratio | 5.93% | 76.12% | 53.78% | 57.49% |
| Debt ratio change over time | -0.97% | -0.19% | -1.19% | 10.71% |
| Dept financing | 2% | 25% | 18% | 44% |
| Current Ratio | 18.93% | 1.14% | 1.03% | 1.29% |
| Quick Ratio | 0% | 0.88% | 0.74% | 1.02% |
| Cash Position Ratio | 17.42% | 0.17% | 0.27% | 0.52% |
| Liquididy | 50% | 21% | 17% | 28% |
| Short-term ratios | CALT | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -1.45% | 47.37% | 17.47% | 7.11% |
| Return on assets | -1.54% | 4% | 10.27% | 3.45% |
| Return on sales | 0% | 27.25% | 40.94% | 25.98% |
| Return on invested capital | 585.53% | 9.88% | -29.27% | 5.48% |
| Profitability | 25% | 52% | 59% | 28% |
| Total debt ratio | 6.19% | 92.44% | 55.58% | 61.53% |
| Debt ratio change over time | -0.97% | 11.97% | -0.93% | 13.81% |
| Dept financing | 2% | 47% | 15% | 42% |
| Current Ratio | 18.93% | 1.14% | 1.03% | 1.29% |
| Quick Ratio | 0% | 0.88% | 0.74% | 1.02% |
| Cash Position Ratio | 17.42% | 0.17% | 0.27% | 0.52% |
| Liquididy | 50% | 23% | 20% | 27% |